Skip to main content
OpenTrials
Completed

NCT Number: NCT04513847

PsoVac: Educational Needs re Vaccines for Biologic Patients With Psoriasis

To determine if there is a need for further education on vaccines with psoriasis patients who are on a biologic. In regards to the COVID-19, it is important that psoriasis patients - whether on a biologic or not - understand whether they can have certain vaccines. That will depend on the type of vaccine that becomes available.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • psoriasis patient

Exclusion criteria

  • no exclusions

Treatment and study plan

Primary outcomes

  1. Percentage of patients not understanding the interaction of vaccines and their biologic, assessed with voluntary survey.

    Time frame: Data will be collected over a span of 3 months

    Assessment is based upon survey responses. By answering multiple questions we will determine if more education is needed based on the answers.

Sponsors and collaborators

Lead sponsor

Dermatrials Research

Other

Registry information

Official study title

PsoVac: A Psoriatic Patient-based Survey on the Understanding of the Use of Vaccines While on Biologics During the Covid-19 Pandemic

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Aug 14, 2020
Registry last updated
Oct 8, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.